Publications
Links to our latest financial and sustainability reports and other recent publications.
Investors
Q1 2025 Financial Results
Grifols first quarter 2025 results.
Showing 226 search results
Press release
Grifols delivers strong results across the board, increasing revenues by 7.4%, Adj EBITDA by 14.2% and improving free cash flow by EUR 209m
Press release
Grifols partners with IBL International to develop advanced biomarker panels for unique clinical diagnostics platform
Press release
Grifols appoints Montse Ribas as Chief Communications and Reputation Officer to strengthen the company's global reputation
Press release
Grifols and Inpeco joining forces to deliver transfusion medicine ‘lab of the future’
Press release
Grifols Phase 2/3 trial shows positive impact of immunoglobulin therapy on post-polio patients
Press release
Grifols expects to reach EUR 10 billion in revenue, EUR 2.9 billion in EBITDA and EUR 3.5+ billion in cumulative cash flow by 2029
Financial Report
Explore our last financial and earnings report.
Sustainability Report
Integrated and Sustainability Annual Report.
Position Paper
The differential value of plasma-derived medicinal products (PDMPs).
Press Kit
Explore our Press Kit to find key facts and figures on Grifols.
Media Contacts
If you're a journalist or media professional with a question, contact our media relations team.